SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Baig Asma H.) "

Sökning: WFRF:(Baig Asma H.)

  • Resultat 1-3 av 3
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Micah, Angela E., et al. (författare)
  • Tracking development assistance for health and for COVID-19 : a review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990-2050
  • 2021
  • Ingår i: The Lancet. - : Elsevier. - 0140-6736 .- 1474-547X. ; 398:10308, s. 1317-1343
  • Forskningsöversikt (refereegranskat)abstract
    • Background The rapid spread of COVID-19 renewed the focus on how health systems across the globe are financed, especially during public health emergencies. Development assistance is an important source of health financing in many low-income countries, yet little is known about how much of this funding was disbursed for COVID-19. We aimed to put development assistance for health for COVID-19 in the context of broader trends in global health financing, and to estimate total health spending from 1995 to 2050 and development assistance for COVID-19 in 2020. Methods We estimated domestic health spending and development assistance for health to generate total health-sector spending estimates for 204 countries and territories. We leveraged data from the WHO Global Health Expenditure Database to produce estimates of domestic health spending. To generate estimates for development assistance for health, we relied on project-level disbursement data from the major international development agencies' online databases and annual financial statements and reports for information on income sources. To adjust our estimates for 2020 to include disbursements related to COVID-19, we extracted project data on commitments and disbursements from a broader set of databases (because not all of the data sources used to estimate the historical series extend to 2020), including the UN Office of Humanitarian Assistance Financial Tracking Service and the International Aid Transparency Initiative. We reported all the historic and future spending estimates in inflation-adjusted 2020 US$, 2020 US$ per capita, purchasing-power parity-adjusted US$ per capita, and as a proportion of gross domestic product. We used various models to generate future health spending to 2050. Findings In 2019, health spending globally reached $8. 8 trillion (95% uncertainty interval [UI] 8.7-8.8) or $1132 (1119-1143) per person. Spending on health varied within and across income groups and geographical regions. Of this total, $40.4 billion (0.5%, 95% UI 0.5-0.5) was development assistance for health provided to low-income and middle-income countries, which made up 24.6% (UI 24.0-25.1) of total spending in low-income countries. We estimate that $54.8 billion in development assistance for health was disbursed in 2020. Of this, $13.7 billion was targeted toward the COVID-19 health response. $12.3 billion was newly committed and $1.4 billion was repurposed from existing health projects. $3.1 billion (22.4%) of the funds focused on country-level coordination and $2.4 billion (17.9%) was for supply chain and logistics. Only $714.4 million (7.7%) of COVID-19 development assistance for health went to Latin America, despite this region reporting 34.3% of total recorded COVID-19 deaths in low-income or middle-income countries in 2020. Spending on health is expected to rise to $1519 (1448-1591) per person in 2050, although spending across countries is expected to remain varied. Interpretation Global health spending is expected to continue to grow, but remain unequally distributed between countries. We estimate that development organisations substantially increased the amount of development assistance for health provided in 2020. Continued efforts are needed to raise sufficient resources to mitigate the pandemic for the most vulnerable, and to help curtail the pandemic for all. Copyright (C) 2021 The Author(s). Published by Elsevier Ltd.
  •  
2.
  • Audouze, Karine, et al. (författare)
  • Evidenced-Based Approaches to Support the Development of Endocrine-Mediated Adverse Outcome Pathways : Challenges and Opportunities
  • 2021
  • Ingår i: Frontiers in Toxicology. - : Frontiers Media S.A.. - 2673-3080. ; 3
  • Tidskriftsartikel (refereegranskat)abstract
    • A transformation of regulatory toxicology is underway to meet the demands of testing increasing numbers of chemicals whilst reducing reliance on in vivo models. This transformation requires a shift from chemical safety assessment largely based on direct empirical observation of apical toxicity outcomes in whole organisms to predictive approaches in which outcomes and risks are inferred from accumulated mechanistic understanding. 
  •  
3.
  • Kortenkamp, Andreas, et al. (författare)
  • Removing Critical Gaps in Chemical Test Methods by Developing New Assays for the Identification of Thyroid Hormone System-Disrupting Chemicals-The ATHENA Project
  • 2020
  • Ingår i: International Journal of Molecular Sciences. - : MDPI. - 1661-6596 .- 1422-0067. ; 21:9
  • Tidskriftsartikel (refereegranskat)abstract
    • The test methods that currently exist for the identification of thyroid hormone system-disrupting chemicals are woefully inadequate. There are currently no internationally validated in vitro assays, and test methods that can capture the consequences of diminished or enhanced thyroid hormone action on the developing brain are missing entirely. These gaps put the public at risk and risk assessors in a difficult position. Decisions about the status of chemicals as thyroid hormone system disruptors currently are based on inadequate toxicity data. The ATHENA project (Assays for the identification of Thyroid Hormone axis-disrupting chemicals: Elaborating Novel Assessment strategies) has been conceived to address these gaps. The project will develop new test methods for the disruption of thyroid hormone transport across biological barriers such as the blood-brain and blood-placenta barriers. It will also devise methods for the disruption of the downstream effects on the brain. ATHENA will deliver a testing strategy based on those elements of the thyroid hormone system that, when disrupted, could have the greatest impact on diminished or enhanced thyroid hormone action and therefore should be targeted through effective testing. To further enhance the impact of the ATHENA test method developments, the project will develop concepts for better international collaboration and development in the area of thyroid hormone system disruptor identification and regulation.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-3 av 3
Typ av publikation
tidskriftsartikel (2)
forskningsöversikt (1)
Typ av innehåll
refereegranskat (3)
Författare/redaktör
Rahmani, Amir Masoud (1)
Dalal, Koustuv (1)
McKee, Martin (1)
Abolhassani, Hassan (1)
Koyanagi, Ai (1)
Harapan, Harapan (1)
visa fler...
Sheikh, Aziz (1)
Adhikari, Tara Balla ... (1)
Hay, Simon I. (1)
Rautio, Arja (1)
Salama, Joseph S. (1)
Abbafati, Cristiana (1)
Dandona, Lalit (1)
Dandona, Rakhi (1)
Zaki, Maysaa El Saye ... (1)
Farzadfar, Farshad (1)
Foigt, Nataliya A. (1)
Hamidi, Samer (1)
Jonas, Jost B. (1)
Khader, Yousef Saleh (1)
Kumar, G. Anil (1)
Lozano, Rafael (1)
Malekzadeh, Reza (1)
Miller, Ted R. (1)
Mokdad, Ali H. (1)
Pereira, David M. (1)
Sanabria, Juan (1)
Sepanlou, Sadaf G. (1)
Tran, Bach Xuan (1)
Vasankari, Tommi Juh ... (1)
Vos, Theo (1)
Vu, Giang Thu (1)
Vu, Linh Gia (1)
Werdecker, Andrea (1)
Xu, Gelin (1)
Yonemoto, Naohiro (1)
Yu, Chuanhua (1)
Murray, Christopher ... (1)
Khubchandani, Jagdis ... (1)
Kosen, Soewarta (1)
Lim, Stephen S. (1)
Majeed, Azeem (1)
Mirrakhimov, Erkin M ... (1)
Owolabi, Mayowa O. (1)
Singh, Jasvinder A. (1)
Tabares-Seisdedos, R ... (1)
Topor-Madry, Roman (1)
Dadras, Omid (1)
Molokhia, Mariam (1)
Hossain, Sheikh Jama ... (1)
visa färre...
Lärosäte
Uppsala universitet (2)
Umeå universitet (1)
Örebro universitet (1)
Mittuniversitetet (1)
RISE (1)
Karlstads universitet (1)
visa fler...
Karolinska Institutet (1)
visa färre...
Språk
Engelska (3)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (3)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy